Akero Therapeutics Inc.
(AKRO) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
27.11
-1.92%
Pre-market Jan 07, 2025, 06:44 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Net Income | -151.76M | -112.03M | -100.78M | -79.21M | -43.76M | -81.71M | -4.56M |
Depreciation & Amortization | 29.00K | 43.00K | 41.00K | 17.00K | -104.00K | n/a | n/a |
Stock-Based Compensation | 21.50M | 23.24M | 10.05M | 6.02M | 1.77M | 121.00K | n/a |
Other Working Capital | -6.03M | -5.43M | 6.45M | -396.00K | 6.89M | -252.00K | 122.00K |
Other Non-Cash Items | -8.46M | 689.00K | 203.00K | 196.00K | -104.00K | 75.91M | -60.00K |
Deferred Income Tax | n/a | n/a | 1.07M | 83.00K | 104.00K | n/a | n/a |
Change in Working Capital | -6.67M | -4.46M | 9.73M | 2.08M | 6.46M | 1.06M | 182.00K |
Operating Cash Flow | -145.37M | -92.52M | -79.68M | -70.80M | -35.63M | -4.63M | -4.38M |
Capital Expenditures | n/a | n/a | n/a | -148.00K | n/a | -5.00M | n/a |
Acquisitions | n/a | n/a | n/a | 9.61K | n/a | n/a | n/a |
Purchase of Investments | -433.12M | -101.45M | -43.56M | -115.04M | -71.51M | n/a | n/a |
Sales Maturities Of Investments | 209.50M | 37.62M | 85.84M | 105.42M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -63.83K | 42.28K | -9.61K | -71.51K | -5.00K | n/a |
Investing Cash Flow | -223.62M | -63.83M | 42.28M | -9.76M | -71.51M | -5.00M | n/a |
Debt Repayment | 15.00M | 10.00M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 373.00K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.89M | 4.43M | 602.00K | 553.00K | 536.00K | 85.01M | 5.00M |
Financial Cash Flow | 353.32M | 255.63M | 602.00K | 203.11M | 95.99M | 85.01M | 5.00M |
Net Cash Flow | -15.67M | 99.29M | -36.80M | 122.54M | -11.15M | 75.38M | 618.00K |
Free Cash Flow | -145.37M | -92.52M | -79.68M | -70.95M | -35.63M | -9.63M | -4.38M |